The Expression of TLR-9, CD86, and CD95 Phenotypes in Circulating B Cells of Patients with Chronic Viral Hepatitis B or C before and after Antiviral Therapy

Table 2

Effects of interferon treatment on clinical profiles of HCV patients.

Group	Drug-responsive ()		Drug-nonresponsive ()
	Before	After	Before	After
ALT (U/L)
Median (range)	56,5 (13,2–229,9)	29,6 (13–69)^*	53,2 (18,4–144,2)	36,3 (15–127)^*
AST (U/L)
Median (range)	34,2 (15,4–111,3)	20,5 (13–47)^*	35,3 (27,1–80)	25,2 (16–65)^*
HCV RNA (log10 copies/mL)
Median (range)	5,4 (5,1–6,9)	2,7 (0,3–3,1)^*	5,5 (5,2–6,7)	5,1 (4,8–6,7)

Data are expressed as median (range) or real case numbers.
< 0.05 versus before treatment.